Sophia Genetics and MD Anderson announced a collaboration to co‑develop an NGS‑based oncology assay and AI-driven bioinformatics pipelines to interpret RNA‑seq and multiomic cancer data, with the partners planning joint R&D programs to improve tumor profiling and trial matching. The initiative aims to streamline genomic testing and interpretation for clinical and research use. Illumina launched Connected Multiomics, a cloud-based software suite that integrates multiomic datasets with AI-driven analytics and workflows for scalable analysis. Illumina positioned the product to support translational research and diagnostic development by simplifying data integration and interpretation. Combined, the partnership and platform releases signal continued momentum in tooling and analytics for precision oncology and multiomic research that could accelerate biomarker discovery and trial-ready assays.